EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 21 October 2021

Blogs

The future of healthcare is systematic digitization and unification of data
15 October 2021

Takeaways from The Value of Innovation conference Read more

Making the impossible, possible

Boehringer Ingelheim
Treatments once known for T2 diabetes are now making it possible to prevent heart failure, stroke and kidney disease,... Read more

Menarini
Novel therapeutics are making recovering from blood cancers like BPDCN possible and could make it possible to treat... Read more

Events

Global Pharmaceutical and Biotechnology Conference
08 November 2021 (Virtual event)

Sustaining innovation and collaboration beyond the pandemic #FTPharma Read more

“Masterclass” Scaling Innovations Emerging from Public-Private Partnerships
26 October 2021 (Virtual event)

The Innovative Medicines Initiative is delighted to invite you to this virtual event. Read more

Investigating the syndemic threat of COVID-19 and chronic disease: The diabetes case
09 November 2021 (Virtual event)

Improved integration of care is the way forward to strengthen chronic disease management in emergencies and beyond Read more

Pandemic Prevention: how Europe can lead the fight against AMR
16 November 2021 (Virtual event)

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. Read more

What we are reading

Innovative Health Initiative reaches new milestone
On 21 October 2021 (EUHealthPPP)

The adoption of the European Parliament Report is a necessary milestone towards the establishment of the new Public-Private... Read more

EFPIA On Why More EU Drug Price Transparency Isn’t The Answer
On 15 October 2021 (Pink Sheet - paywall)

As discussions continue over the European Commission’s plans to overhaul the EU pharmaceutical legislation, the R&D-based... Read more

How France overcame vaccine hesitancy - and where Romania went wrong
On 08 September 2021 (Vaccines Today)

After a slow start, France boasts world-beating vaccine uptake. What happened?’ Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu